237 related articles for article (PubMed ID: 26776587)
1. Effect of atenolol on heart rate, arrhythmias, blood pressure, and dynamic left ventricular outflow tract obstruction in cats with subclinical hypertrophic cardiomyopathy.
Jackson BL; Adin DB; Lehmkuhl LB
J Vet Cardiol; 2015 Dec; 17 Suppl 1():S296-305. PubMed ID: 26776587
[TBL] [Abstract][Full Text] [Related]
2. Heart rate and arrhythmia frequency of normal cats compared to cats with asymptomatic hypertrophic cardiomyopathy.
Jackson BL; Lehmkuhl LB; Adin DB
J Vet Cardiol; 2014 Dec; 16(4):215-25. PubMed ID: 25465341
[TBL] [Abstract][Full Text] [Related]
3. Acute effects of ivabradine on dynamic obstruction of the left ventricular outflow tract in cats with preclinical hypertrophic cardiomyopathy.
Blass KA; Schober KE; Li X; Scansen BA; Bonagura JD
J Vet Intern Med; 2014; 28(3):838-46. PubMed ID: 24597596
[TBL] [Abstract][Full Text] [Related]
4. The effect of atenolol on NT-proBNP and troponin in asymptomatic cats with severe left ventricular hypertrophy because of hypertrophic cardiomyopathy: a pilot study.
Jung SW; Kittleson MD
J Vet Intern Med; 2011; 25(5):1044-9. PubMed ID: 21781160
[TBL] [Abstract][Full Text] [Related]
5. Acute pharmacodynamic effects of pimobendan in client-owned cats with subclinical hypertrophic cardiomyopathy.
Oldach MS; Ueda Y; Ontiveros ES; Fousse SL; Visser LC; Stern JA
BMC Vet Res; 2021 Feb; 17(1):89. PubMed ID: 33622315
[TBL] [Abstract][Full Text] [Related]
6. Atenolol in cats with subclinical hypertrophic cardiomyopathy: a double-blind, placebo-controlled, randomized clinical trial of effect on quality of life, activity, and cardiac biomarkers.
Coleman AE; DeFrancesco TC; Griffiths EH; Lascelles BDX; Kleisch DJ; Atkins CE; Keene BW
J Vet Cardiol; 2020 Aug; 30():77-91. PubMed ID: 32707333
[TBL] [Abstract][Full Text] [Related]
7. [Mitral valve dysplasia in a cat causing reversible left ventricular hypertrophy and dynamic outflow tract obstruction].
Kuijpers NW; Szatmári V
Tijdschr Diergeneeskd; 2011 May; 136(5):326-31. PubMed ID: 21614848
[TBL] [Abstract][Full Text] [Related]
8. Effect of treatment with atenolol on 5-year survival in cats with preclinical (asymptomatic) hypertrophic cardiomyopathy.
Schober KE; Zientek J; Li X; Fuentes VL; Bonagura JD
J Vet Cardiol; 2013 Jun; 15(2):93-104. PubMed ID: 23684504
[TBL] [Abstract][Full Text] [Related]
9. Effects of ivabradine on heart rate and left ventricular function in healthy cats and cats with hypertrophic cardiomyopathy.
Riesen SC; Schober KE; Smith DN; Otoni CC; Li X; Bonagura JD
Am J Vet Res; 2012 Feb; 73(2):202-12. PubMed ID: 22280379
[TBL] [Abstract][Full Text] [Related]
10. Left ventricular outflow tract pressure gradient changes after carvedilol-disopyramide cotherapy in a cat with hypertrophic obstructive cardiomyopathy.
Hori Y; Fujimoto E; Nishikawa Y; Nakamura T
J Vet Cardiol; 2020 Jun; 29():40-46. PubMed ID: 32464577
[TBL] [Abstract][Full Text] [Related]
11. Holter monitoring demonstrates that ventricular arrhythmias are common in cats with decompensated and compensated hypertrophic cardiomyopathy.
Bartoszuk U; Keene BW; Baron Toaldo M; Pereira N; Summerfield N; Novo Matos J; Glaus TM
Vet J; 2019 Jan; 243():21-25. PubMed ID: 30606435
[TBL] [Abstract][Full Text] [Related]
12. Effect of cibenzoline and atenolol administration on dynamic left ventricular obstruction due to sigmoid-shaped septum.
Ozaki K; Sakuma I; Mitsuma K; Suzuki T; Tsuchida K; Takahashi K; Miida T; Oda H
Circ J; 2008 Dec; 72(12):2087-91. PubMed ID: 18854617
[TBL] [Abstract][Full Text] [Related]
13. Patterns of cardiac dysfunction coinciding with exertional breathlessness in hypertrophic cardiomyopathy.
Maras D; Chung R; Duncan A; Li W; Thorp C; Mörner S; Lindqvist P; Henein MY
Int J Cardiol; 2013 Dec; 170(2):233-8. PubMed ID: 24210420
[TBL] [Abstract][Full Text] [Related]
14. Effects of atenolol on left atrial and left ventricular function in healthy cats and in cats with hypertrophic cardiomyopathy.
Sugimoto K; Aoki T; Fujii Y
J Vet Med Sci; 2020 May; 82(5):546-552. PubMed ID: 32188801
[TBL] [Abstract][Full Text] [Related]
15. Paradoxical response to exercise in asymptomatic hypertrophic cardiomyopathy: a new description of outflow tract obstruction dynamics.
Lafitte S; Reant P; Touche C; Pillois X; Dijos M; Arsac F; Peyrou J; Montaudon M; Ritter P; Roudaut R; Demaria A
J Am Coll Cardiol; 2013 Aug; 62(9):842-50. PubMed ID: 23810875
[TBL] [Abstract][Full Text] [Related]
16. Doppler echocardiographic evaluation of midventricular obstruction in cats with hypertrophic cardiomyopathy.
MacLea HB; Boon JA; Bright JM
J Vet Intern Med; 2013; 27(6):1416-20. PubMed ID: 24001306
[TBL] [Abstract][Full Text] [Related]
17. Ambulatory electrocardiogram recordings in cats with primary asymptomatic hypertrophic cardiomyopathy.
Hanås S; Tidholm A; Holst BS
J Feline Med Surg; 2017 Feb; 19(2):158-164. PubMed ID: 26620648
[TBL] [Abstract][Full Text] [Related]
18. End-stage hypertrophic cardiomyopathy in a cat.
White AJ
Can Vet J; 2015 May; 56(5):509-11. PubMed ID: 25969586
[TBL] [Abstract][Full Text] [Related]
19. Echocardiographic assessment of left ventricular geometry and the mitral valve apparatus in cats with hypertrophic cardiomyopathy.
Schober K; Todd A
J Vet Cardiol; 2010 Apr; 12(1):1-16. PubMed ID: 20185379
[TBL] [Abstract][Full Text] [Related]
20. Doppler echocardiographic effects of medetomidine on dynamic left ventricular outflow tract obstruction in cats.
Lamont LA; Bulmer BJ; Sisson DD; Grimm KA; Tranquilli WJ
J Am Vet Med Assoc; 2002 Nov; 221(9):1276-81. PubMed ID: 12418692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
